William Blair Issues Negative Estimate for USPH Earnings

U.S. Physical Therapy, Inc. (NYSE:USPH) – William Blair reduced their Q1 2025 earnings per share (EPS) estimates for shares of U.S. Physical Therapy in a research note issued on Tuesday, March 11th. William Blair analyst J. Haase now anticipates that the company will post earnings of $0.48 per share for the quarter, down from their previous estimate of $0.56. William Blair has a “Market Perform” rating on the stock. The consensus estimate for U.S. Physical Therapy’s current full-year earnings is $2.67 per share. William Blair also issued estimates for U.S. Physical Therapy’s Q2 2025 earnings at $0.71 EPS, Q3 2025 earnings at $0.77 EPS, Q4 2025 earnings at $0.76 EPS, FY2025 earnings at $2.73 EPS and FY2026 earnings at $3.05 EPS.

A number of other analysts have also recently commented on the company. Citizens Jmp raised U.S. Physical Therapy to a “strong-buy” rating in a research note on Monday, December 16th. JPMorgan Chase & Co. upped their price target on U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Tuesday, December 3rd. Barrington Research lowered their price target on U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating for the company in a research note on Friday, February 28th. JMP Securities initiated coverage on U.S. Physical Therapy in a research note on Monday, December 16th. They issued an “outperform” rating and a $113.00 price target for the company. Finally, Bank of America upgraded U.S. Physical Therapy from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $100.00 to $115.00 in a research report on Monday, December 16th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $111.50.

U.S. Physical Therapy Stock Performance

Shares of USPH stock opened at $77.65 on Thursday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. The stock has a market cap of $1.18 billion, a PE ratio of 82.60, a price-to-earnings-growth ratio of 3.54 and a beta of 1.51. The stock has a 50-day moving average of $86.84 and a 200-day moving average of $87.50. U.S. Physical Therapy has a one year low of $76.18 and a one year high of $113.63.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing analysts’ consensus estimates of $0.69 by ($0.04). The company had revenue of $180.45 million during the quarter, compared to the consensus estimate of $173.10 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%.

U.S. Physical Therapy Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 14th will be given a $0.45 dividend. The ex-dividend date is Friday, March 14th. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.44. This represents a $1.80 annualized dividend and a dividend yield of 2.32%. U.S. Physical Therapy’s payout ratio is currently 97.83%.

Insider Activity at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the company’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $82.11, for a total transaction of $142,050.30. Following the completion of the transaction, the chief operating officer now owns 7,168 shares of the company’s stock, valued at $588,564.48. This represents a 19.44 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 1.70% of the stock is owned by insiders.

Hedge Funds Weigh In On U.S. Physical Therapy

A number of large investors have recently bought and sold shares of the company. Vanguard Group Inc. boosted its position in U.S. Physical Therapy by 0.6% during the 4th quarter. Vanguard Group Inc. now owns 1,084,197 shares of the company’s stock worth $96,179,000 after acquiring an additional 6,393 shares during the last quarter. Copeland Capital Management LLC boosted its position in U.S. Physical Therapy by 9.5% during the 4th quarter. Copeland Capital Management LLC now owns 839,356 shares of the company’s stock worth $74,459,000 after acquiring an additional 72,715 shares during the last quarter. State Street Corp raised its stake in shares of U.S. Physical Therapy by 17.5% during the 3rd quarter. State Street Corp now owns 667,868 shares of the company’s stock worth $56,522,000 after purchasing an additional 99,244 shares in the last quarter. Southernsun Asset Management LLC raised its stake in shares of U.S. Physical Therapy by 4.5% during the 4th quarter. Southernsun Asset Management LLC now owns 571,809 shares of the company’s stock worth $50,725,000 after purchasing an additional 24,698 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in shares of U.S. Physical Therapy by 1.9% during the 4th quarter. Dimensional Fund Advisors LP now owns 426,298 shares of the company’s stock worth $37,818,000 after purchasing an additional 7,890 shares in the last quarter.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.